Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 707 4,5 2?
Displaying drugs 11776 - 11800 of 12499 in total
Experimental
Matched Iupac: … 4-amino-N-(5-methylpyrimidin-2-yl)benzene-1-sulfonamide …
Experimental
Matched Iupac: … trimethyl[1-(10H-phenothiazin-10-yl)propan-2-yl]azanium …
Dexchlorpheniramine is a potent S-enantiomer of chlorpheniramine. The salt form dexchlorpheniramine maleate as the active ingredient is available as a prescription drug indicated for adjunctive therapy for allergic and anaphylactic reactions. It is an antihistamine drug with anticholinergic (drying) and sedative actions. It disrupts histamine signaling by competing with histamine...
Experimental
Investigational
Matched Iupac: … [(3S)-3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl]dimethylamine …
Experimental
Matched Iupac: … 9-[3-(dimethylamino)propyl]-2-methoxy-9H-thioxanthen-9-ol …
Experimental
Matched Iupac: … (1S,2R,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl acetate …
Experimental
Matched Iupac: … (1R,4S)-3,3-dibromo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one …
Experimental
Matched Iupac: … (1R,5R)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-2-one …
Investigational
Matched Iupac: … (2R)-2-acetamido-3-sulfanylpropanoic acid; (2S)-2,6-diaminohexanoic acid …
Progabide is an analog and prodrug of gamma-aminobutyric acid. It is commonly used in the treatment of epilepsy. It has agonistic activity for both the GABAA and GABAB receptors. In clinical trials, progabide has been investigated for Parkinson's disease, schizophrenia, clinical depression and anxiety disorder; its therapeutic effectiveness in these...
Experimental
Matched Iupac: … 4-{[(4-chlorophenyl)(5-fluoro-2-hydroxyphenyl)methylidene]amino}butanimidic acid …
Experimental
Matched Iupac: … (2S,3S,4R,5S,6S)-2-methoxy-6-methyloxane-3,4,5-triol …
Experimental
Matched Iupac: … (2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol …
Experimental
Matched Iupac: … (2S)-2-amino-6-[5-(dimethylamino)naphthalene-1-sulfonamido]hexanoic acid …
Experimental
Matched Iupac: … 89-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81,84,87 …
Investigational
Matched Iupac: … 4-{[2-(2,4-dinitrophenyl)hydrazin-1-ylidene](4-hydroxyphenyl)methyl}phenol …
Experimental
Vet approved
Matched Iupac: … 2-{[(3-methylpent-1-yn-3-yl)oxy]carbonyl}benzoic acid …
Talsaclidine has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Iupac: … (3R)-3-(prop-2-yn-1-yloxy)-1-azabicyclo[2.2.2]octane …
Oltipraz has been used in trials studying the treatment and prevention of Lung Cancer, Liver Fibrosis, Liver Cirrhosis, and Non-alcoholic Fatty Liver Disease.
Investigational
Matched Iupac: … 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione …
Experimental
Matched Iupac: … 1,1-diethyl-3-[(2-hydroxy-2,2-diphenylacetyl)oxy]pyrrolidin-1-ium …
Experimental
Matched Iupac: … 1-{2-[3-(2,2-diphenylethyl)-1,2,4-oxadiazol-5-yl]ethyl}piperidine …
Experimental
Matched Iupac: … 4-amino-N-(1-benzylpiperidin-4-yl)-5-chloro-2-methoxybenzamide …
Experimental
Matched Iupac: … ethyl N-{10-[3-(diethylamino)propanoyl]-10H-phenothiazin-2-yl}carbamate …
Experimental
Matched Iupac: … diethyl({2-[3-(1-phenylpropyl)-1,2,4-oxadiazol-5-yl]ethyl})amine …
Experimental
Matched Iupac: … 4-(morpholin-4-yl)butan-2-yl 4-phenyloxane-4-carboxylate …
Lucerastat is under investigation in clinical trial NCT03425539 (Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease).
Investigational
Matched Iupac: … (2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol …
Carfentanil, C-11 is under investigation in clinical trial NCT01899170 (Towards Individualized Deep Brain Stimulation Treatment of Chronic Neuropathic Pain).
Investigational
Matched Iupac: … (11C)methyl 1-(2-phenylethyl)-4-(N-phenylpropanamido)piperidine-4-carboxylate …
Displaying drugs 11776 - 11800 of 12499 in total